Suau Salvador J, DeBlieux Peter M C
Louisiana State University, University Medical Center of New Orleans, 2000 Canal Street, D&T 2nd Floor - Suite 2720, New Orleans, LA 70112, USA.
Louisiana State University, University Medical Center of New Orleans, 2000 Canal Street, D&T 2nd Floor - Suite 2720, New Orleans, LA 70112, USA.
Emerg Med Clin North Am. 2016 Feb;34(1):15-37. doi: 10.1016/j.emc.2015.08.002.
Acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations are the most common respiratory diseases requiring emergent medical evaluation and treatment. Asthma and COPD are chronic, debilitating disease processes that have been differentiated traditionally by the presence or absence of reversible airflow obstruction. Asthma and COPD exacerbations impose an enormous economic burden on the US health care budget. In daily clinical practice, it is difficult to differentiate these 2 obstructive processes based on their symptoms, and on their nearly identical acute treatment strategies; major differences are important when discussing anatomic sites involved, long-term prognosis, and the nature of inflammatory markers.
急性哮喘和慢性阻塞性肺疾病(COPD)急性加重是最常见的需要紧急医学评估和治疗的呼吸道疾病。哮喘和COPD是慢性、使人衰弱的疾病过程,传统上是根据是否存在可逆性气流受限来区分的。哮喘和COPD急性加重给美国医疗保健预算带来了巨大的经济负担。在日常临床实践中,很难根据症状以及几乎相同的急性治疗策略来区分这两种阻塞性疾病过程;在讨论所涉及的解剖部位、长期预后和炎症标志物的性质时,主要差异很重要。